ZYMEWORKS INC (ZYME) Top Institutional Shareholders

ZYMEWORKS INC (ZYME) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $1.75B in ZYME holdings during the latest filing period.

Ecor1 Capital, Llc is currently the largest disclosed institutional shareholder of ZYME tracked by InsiderSet, reporting ownership valued at approximately $575.18M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $531.53M, representing an estimated loss of -7.59% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 72% of the total disclosed ZYME value among the investors covered in this analysis. Major shareholders include Ecor1 Capital, Llc, Rubric Capital Management Lp, Blackrock, Inc., and several other long-term asset managers with concentrated positions in ZYMEWORKS INC (ZYME).

This page ranks the largest institutional ZYME shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

209

Total Reported Value

$1.75B

Largest Holder

Ecor1 Capital, Llc

Largest Position

$575.18M

Insider Transactions (90d)

0

Latest Filing Quarter

Q1 2026

New Institutional Positions

163

Funds Exiting Positions

0

Page 1 of 5
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Ecor1 Capital, Llc24.58%22,970,388$575,178,516$531,534,778-$43,643,738-7.59%
Rubric Capital Management Lp2.15%7,000,000$175,280,000$161,980,000-$13,300,000-7.59%
Blackrock, Inc.0.00%4,553,888$114,029,354$105,376,968-$8,652,386-7.59%
Bvf Inc/Il2.98%3,734,142$93,502,916$86,408,046-$7,094,870-7.59%
Perceptive Advisors Llc1.74%3,510,078$87,892,353$81,223,205-$6,669,148-7.59%
Morgan Stanley0.00%2,480,568$62,113,426$57,400,344-$4,713,082-7.59%
Bnp Paribas Asset Management Holding S.A.0.06%1,908,039$47,777,297$44,152,022-$3,625,275-7.59%
Vanguard Capital Management Llc0.00%1,705,580$42,707,723$39,467,121-$3,240,602-7.59%
Citadel Advisors Llc0.02%1,150,018$28,796,451$26,611,417-$2,185,034-7.59%
Dimensional Fund Advisors Lp0.01%1,139,135$28,518,914$26,359,584-$2,159,330-7.57%
Nextech Invest, Ltd.1.96%1,113,946$27,893,208$25,776,710-$2,116,498-7.59%
State Street Corp0.00%1,011,777$25,334,896$23,412,520-$1,922,376-7.59%
Capricorn Fund Managers Ltd3.93%1,007,210$25,220,538$23,306,839-$1,913,699-7.59%
Deutsche Bank Ag\0.01%921,250$23,068,100$21,317,725-$1,750,375-7.59%
Arrowstreet Capital, Limited Partnership0.01%743,898$18,627,206$17,213,800-$1,413,406-7.59%
Assenagon Asset Management S.A.0.03%727,986$18,228,769$16,845,596-$1,383,173-7.59%
Fmr Llc0.00%667,153$16,705,506$15,437,920-$1,267,586-7.59%
Geode Capital Management, Llc0.00%659,940$16,524,344$15,271,012-$1,253,332-7.58%
Nuveen, Llc0.00%651,662$16,317,616$15,079,459-$1,238,157-7.59%
Goldman Sachs Group Inc0.00%599,486$15,011,130$13,872,106-$1,139,024-7.59%
Mpm Bioimpact Llc1.09%565,249$14,153,835$13,079,862-$1,073,973-7.59%
Prosight Management, Lp2.21%539,049$13,497,787$12,473,594-$1,024,193-7.59%
Qube Research & Technologies Ltd0.02%511,937$12,818,902$11,846,222-$972,680-7.59%
Vanguard Portfolio Management Llc0.00%499,875$12,516,870$11,567,108-$949,763-7.59%
Redmile Group, Llc0.82%491,654$12,311,016$11,376,874-$934,142-7.59%
Hillsdale Investment Management Inc.0.24%345,622$8,654,375$7,997,693-$656,682-7.59%
Summittx Capital, L.P.0.26%321,427$8,048,532$7,437,821-$610,711-7.59%
Northern Trust Corp0.00%320,210$8,018,059$7,409,659-$608,400-7.59%
Ubs Am, A Distinct Business Unit Of Ubs Asset Management Americas Llc0.00%319,385$7,997,401$7,390,569-$606,832-7.59%
Royce & Associates Lp0.07%299,202$7,492,018$6,923,534-$568,484-7.59%
Picton Mahoney Asset Management0.07%256,690$6,427,518$5,939,807-$487,711-7.59%
Granahan Investment Management, Llc0.30%250,773$6,279,356$5,802,887-$476,469-7.59%
Bank Of America Corp0.00%236,754$5,928,321$5,478,488-$449,833-7.59%
D. E. Shaw & Co., Inc.0.00%235,621$5,899,950$5,452,270-$447,680-7.59%
Jane Street Group, Llc0.01%226,967$5,683,253$5,252,016-$431,237-7.59%
Panagora Asset Management Inc0.02%206,854$5,179,624$4,786,602-$393,022-7.59%
Man Group Plc0.01%189,890$4,754,846$4,394,055-$360,791-7.59%
Wells Fargo & Company/Mn0.00%189,636$4,748,478$4,388,177-$360,301-7.59%
Charles Schwab Investment Management Inc0.00%185,124$4,635,505$4,283,769-$351,736-7.59%
Federated Hermes, Inc.0.01%182,410$4,567,547$4,220,967-$346,580-7.59%
Raymond James Financial Inc0.00%176,411$4,417,332$4,082,151-$335,181-7.59%
Ubs Group Ag0.00%171,779$4,301,346$3,974,966-$326,380-7.59%
Silvercrest Asset Management Group Llc0.03%163,649$4,097,771$3,786,838-$310,933-7.59%
Kennedy Capital Management Llc0.08%148,226$3,711,579$3,429,950-$281,629-7.59%
Xtx Topco Ltd0.06%143,882$3,602,805$3,329,429-$273,376-7.59%
Diadema Partners Lp1.47%142,132$3,558,985$3,288,934-$270,051-7.59%
Wellington Management Group Llp0.00%138,690$3,472,798$3,209,287-$263,511-7.59%
Invesco Ltd.0.00%125,630$3,145,775$2,907,078-$238,697-7.59%
Bank Of New York Mellon Corp0.00%124,105$3,107,587$2,871,790-$235,797-7.59%
Citigroup Inc0.00%114,327$2,862,749$2,645,527-$217,222-7.59%

Frequently asked questions about ZYME

  • Who owns the most ZYME stock?

    The largest holders of ZYME are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for ZYMEWORKS INC (ZYME).

  • Is ZYME widely held by superinvestors?

    Many widely followed stocks like ZYME appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly ZYME is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.